bluebird bio, Inc. (BLUE) financial statements (2020 and earlier)

Company profile

Business Address 60 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,1061,3851,290704518474206
Cash and cash equivalents327403759279164348206
Short-term investments779983532425354126 
Prepaid expense332021    
Other undisclosed current assets13141120666
Total current assets:1,1521,4191,323724524480212
Noncurrent Assets
Operating lease, right-of-use asset186
Property, plant and equipment151247200157831611
Long-term investments and receivables13250632418034818 
Long-term investments13250632418034818 
Intangible assets, net (including goodwill)272630343841
Goodwill131313131313 
Intangible assets, net (excluding goodwill)141317212428 
Other noncurrent assets79452423101 
Other undisclosed noncurrent assets      1
Total noncurrent assets:5758245783944787712
TOTAL ASSETS:1,7272,2431,9011,1181,002557224
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities115181314686
Accounts payable43181314634
Accrued liabilities27    0 
Employee-related liabilities45    52
Deferred revenue8
Debt20      
Business combination, contingent consideration, liability     0
Deferred revenue and credits26662626
Contract with customer, liability19
Other liabilities 9957552810
Other undisclosed current liabilities8011   72
Total current liabilities:2241469675404335
Noncurrent Liabilities
Long-term debt and lease obligation171      
Operating lease, liability171
Liabilities, other than long-term debt20252754502338
Deferred revenue and credits2451441437
Deferred revenue10
Contract with customer, liability16
Deferred tax liabilities, net    21
Other liabilities2300000
Business combination, contingent consideration, liability852356
Other undisclosed noncurrent liabilities2818715512062  
Total noncurrent liabilities:2192111821741112338
Total liabilities:4423582772491526573
Stockholders' equity
Stockholders' equity attributable to parent1,2851,8851,623869850491152
Common stock1100000
Additional paid in capital3,5683,3872,5411,4481,167638250
Accumulated other comprehensive loss(2)(4)(4)(1)(2)(0) 
Accumulated deficit(2,282)(1,499)(914)(578)(314)(147)(99)
Total stockholders' equity:1,2851,8851,623869850491152
TOTAL LIABILITIES AND EQUITY:1,7272,2431,9011,1181,002557224

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues4555356142520
Revenue, net226142520
Cost of revenue(6)(1)     
Cost of goods and services sold(3)(1)     
Gross profit:3954356142520
Operating expenses(854)(627)(368)(274)(183)(90)(46)
Other undisclosed operating income 1   41
Operating loss:(815)(572)(332)(268)(169)(61)(25)
Nonoperating income (expense)(10)2(1)420(0)
Investment income, nonoperating    200
Foreign currency transaction gain (loss), before tax     (0)0
Other nonoperating income (expense)(10)2(1)410(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (0)
Loss from continuing operations before equity method investments, income taxes:(825)(570)(333)(264)(167)(61)(25)
Other undisclosed income (loss) from continuing operations before income taxes3515(2)    
Loss from continuing operations before income taxes:(790)(555)(335)(264)(167)(61)(25)
Income tax expense (benefit)1(0)(0)1(0)12 
Net loss available to common stockholders, diluted:(790)(556)(336)(264)(167)(49)(25)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(790)(556)(336)(264)(167)(49)(25)
Other comprehensive income (loss)21(3)1(2)(0) 
Comprehensive loss, net of tax, attributable to parent:(788)(555)(339)(262)(169)(49)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: